Status:
WITHDRAWN
Botox for Treatment of TMJ Disorder With Bruxism
Lead Sponsor:
Washington University School of Medicine
Conditions:
Temporomandibular Joint Disorders
Bruxism
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Hypothesis: Myofascial temporomandibular joint disorder and related symptoms are associated with mandibular condyle and temporal fossa overloading secondary to temporalis and masseter muscle hyperacti...
Detailed Description
The study will enroll 32 patients with myofascial TMD. Patient will be aged 18-65. Exclusion criteria will include neuromuscular diseases, prior botox injections within previous 12 months, pregnancy, ...
Eligibility Criteria
Inclusion
- aged 18-65 persons with a diagnosis of myofascial temporomandibular joint disorder refractory to conservative treatment for 6 months
Exclusion
- pregnancy
- rheumatoid arthritis
- ankylosing spondylitis
- psoriatic arthritis
- fibromyalgia
- neuropathic pain
- pain of dental origin
- muscle relaxant use
- aminoglycoside use
- prior Botox use
- neuropathic pain
- trigeminal neuralgia
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT02202070
Start Date
January 1 2015
End Date
December 1 2015
Last Update
January 23 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Washington University School of Medicine
St Louis, Missouri, United States, 63110